<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04228016</url>
  </required_header>
  <id_info>
    <org_study_id>RHINASTENT</org_study_id>
    <nct_id>NCT04228016</nct_id>
  </id_info>
  <brief_title>Efficacy of an Intranasal Stent on Nasal Obstruction at Night</brief_title>
  <acronym>RHINASTENT</acronym>
  <official_title>Efficacy of an Intranasal Stent on Nasal Obstruction at Night: A Prospective Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal Creteil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seven Dreamers Europe SAS</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Intercommunal Creteil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to demonstrate a decrease with normalization of nasal resistance in the
      forward decubital position and with an intra-nasal stent in patients with nasal obstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients consulting for nasal obstruction at night and who have functional nasal test
      with pathological resistance in decubitus position are included.

      Functional nasal test (non invasive tests) will be performed before and after intranasal
      introduction of a stent: anterior rhinomanometry to measure nasal function by the measure of
      resistance and acoustic rhinometry to measure the geometry of nasal fossa by the measure of
      minimal sectional cross area sitting, after 30 minutes of decubitus then new measurements
      with a stent in decubitus position in each nostril .
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 27, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nasal resistance in anterior rhinomanometry (sPa/ml/sec)</measure>
    <time_frame>Day 15</time_frame>
    <description>Change grom Baseline of Nasal resistance in anterior rhinomanometry. Sitting, lying in the meadow and Per stent nasal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nasal Obstruction and Septoplasty Effectiveness (NOSE)</measure>
    <time_frame>Day 15</time_frame>
    <description>Scale [0-100]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analog visual scale (EVA) of nocturnal nasal obstruction</measure>
    <time_frame>Day 15</time_frame>
    <description>Scale [0-10]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sino-Nasal Outcome Test 22 (SNOT-22) questionary</measure>
    <time_frame>Day 15</time_frame>
    <description>Scale [0-100]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale (ESS)</measure>
    <time_frame>Day 15</time_frame>
    <description>Scale [0-24]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance</measure>
    <time_frame>Day 15</time_frame>
    <description>Questionnaire on the use or non-use of the stent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent satisfaction</measure>
    <time_frame>Day 15</time_frame>
    <description>Number of patients satisfied with the stent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent tolerance</measure>
    <time_frame>Day 15</time_frame>
    <description>Questionnaire on stent tolerance or non-tolerance</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">46</enrollment>
  <condition>Nasal Obstruction</condition>
  <arm_group>
    <arm_group_label>Experimental: Device : nasal airway stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients consulting for predominantly nocturnal nasal obstruction who have benefited from Nasal Respiratory Functional Exploration with detection of pathological resistance in the decubitus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device: nastent™</intervention_name>
    <description>Patients with Nasal obstruction at night, will be used intrasal stent during 15 nights. These are flexible silicone tubes that are lubricated and easy to insert into the nasal cavities, which would restore the permeability of the nasal cavities.</description>
    <arm_group_label>Experimental: Device : nasal airway stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Volontary patient

          2. Over 18 years old or more.

          3. Complain of a nasal obstruction more important (or only) at night (in decubitus
             position)

        Exclusion Criteria:

          1. Unability to sign the consent form

          2. Allergy of stent component

          3. Perforation of nasal septum

          4. Haemostasis disorder or anticoagulant therapy

          5. Bilateral obstructive septal deviation ou polyposis induce inability to introduce the
             stent in the nasal cavities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jung Camille, MD</last_name>
    <phone>01.57.02.22.68</phone>
    <email>camille.jung@chicreteil.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal</name>
      <address>
        <city>Créteil</city>
        <state>Ile De France</state>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilie BEQUIGNON</last_name>
      <email>emilie.bequignon@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emilie BEQUIGNON</last_name>
      <email>emilie.bequignon@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 10, 2020</study_first_submitted>
  <study_first_submitted_qc>January 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2020</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nasal Obstruction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

